The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares
STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) – At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve the board’s previous decision on the preferential issue of shares. The general meeting approved the board’s previous decision of June 16, 2025 regarding […]